The Centre of Excellence is a platform for sharing insights on the evolving access and evidence landscape.
The topics featured in this quarterly program were shaped through early engagement with payers, HTA decision-makers, policy leaders, and access teams across the EU5, US, LATAM, and APAC.
Insights will be shared via Factsheets, Webinars and Lunch + Learn sessions. So please look out for the publications.
Content calendar August - October 2025
August
- Value CMS Cell & Gene Therapy Access Model
- HTA & JCA Requirements for Rare Diseases
- China’s Paradigm Shift: How Eastern Innovation could Reshape Access
- AI in Market Access: What It Can and Cannot Do
- Value of 2nd-to-Market Gene Therapies
September
- Global Launch Sequencing Strategies
- Impact of the Inflation Reduction Act on US Pricing & Access
- Country-Level Access Roadmaps
October
- Recognised RWE Data Sources for HTAs
- Sustainable access solutions ahead of formal reimbursement
- Pricing of early access programs